Our results show that nucleolin and kallistatin are overexpressed in tumor-associated blood vessels, and define a role for nucleolin as a kallistatin receptor responsible for its suppressive actions on tumor angiogenesis and cancer cell growth. This evidence concerns the gene NUCLEOLIN and neoplasm.